Tag Archives: Ebola vaccine

Ebola vaccine: Promising single-dose vaccine developed

A single dose of an experimental Ebola vaccine has been found to protect monkeys against the strain of the deadly virus that killed thousands of people in West Africa last year. “These findings may pave the way for the identification and manufacture of safer, single dose, high efficiency vaccines to combat current and future Ebola outbreaks,” said Thomas Geisbert, professor ...

Read More »

GSK/NIH Ebola Vaccine Trials at Oxford Yield Positive Results, What Next?

GSK/NIH Ebola vaccine clinical trials by Oxford University showed that the vaccine has an acceptable safety profile at the doses tested, and is able to generate an immune response. “The vaccine was well tolerated. Its safety profile is pretty much as we had hoped,” said Professor Adrian Hill of the Jenner Institute at Oxford University, who led the trial. This ...

Read More »

Johnson & Johnson Given $115 Mln to Speed up Ebola Vaccine Trial

Johnson & Johnson, which has started its clinical trials for Ebola vaccine, was given $115 million (100 million euro) from Europe’s Innovative Medicines Initiative to speed up its development. The has started its clinical trials earlier this week of its two-injection vaccine, which uses a booster from Denmark’s Bavarian Nordic. This will be the third vaccine to enter human testing ...

Read More »

Newlink Genetics, Merck to Resume Ebola Vaccine Trials on $30 Million Contract

NewLink Genetics Corporation and Merck have been given the nod to go ahead with the trials by the Biomedical Advanced Research and Development Authority (BARDA) of the United States Department of Health and Human Services (HHS) and awarded the contract worth $30 million to NG subsidiary BioProtection Systems. BioProtection Systems will take up the trial of the rVSV-EBOV (Ebola) vaccine, ...

Read More »

Ebola vaccine trial suspended in Geneva over joint pains

A clinical trial of Ebola vaccine, developed by pharmaceutical firms Merck and NewLink, has been suspended after 4 patients complained of joint pains in their limbs. The University of Geneva hospital said, “They are all fine and being monitored regularly by the medical team leading the study,” in a statement. These joint pain symptoms in hands and feet were “benign ...

Read More »

Experimental Ebola Vaccine Seems to Be Safe in Test

An experimental vaccine to prevent Ebola virus disease has been found to be well-tolerated and produced immune system responses in all 20 healthy adults who received it in a Phase 1 clinical trial, researchers report. The trials were conducted at US National Institutes of Health’s clinical centre in Bethesda, Maryland. The candidate vaccine is co-developed by the NIH’s National Institute ...

Read More »